208 related articles for article (PubMed ID: 37552906)
1. Unveiling the mystery of ILC3s: Their functions and interactions in mucosal immunity.
Liang B; Xing D
Int Immunopharmacol; 2023 Oct; 123():110772. PubMed ID: 37552906
[TBL] [Abstract][Full Text] [Related]
2. Understanding Type 3 Innate Lymphoid Cells and Crosstalk with the Microbiota: A Skin Connection.
To TT; Oparaugo NC; Kheshvadjian AR; Nelson AM; Agak GW
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396697
[TBL] [Abstract][Full Text] [Related]
3. Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms.
Castleman MJ; Dillon SM; Purba CM; Cogswell AC; Kibbie JJ; McCarter MD; Santiago ML; Barker E; Wilson CC
Front Immunol; 2019; 10():649. PubMed ID: 30984202
[TBL] [Abstract][Full Text] [Related]
4. Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells.
Mori A; Ohno H; Satoh-Takayama N
Semin Immunopathol; 2024 Jan; 45(4-6):509-519. PubMed ID: 38305897
[TBL] [Abstract][Full Text] [Related]
5. Intermittent fasting promotes type 3 innate lymphoid cells secreting IL-22 contributing to the beigeing of white adipose tissue.
Chen H; Sun L; Feng L; Han X; Zhang Y; Zhai W; Zhang Z; Mulholland M; Zhang W; Yin Y
Elife; 2024 Mar; 12():. PubMed ID: 38536726
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between the gut microbiota and innate lymphoid cells in intestinal mucosal immunity.
Guo Y; Liu Y; Rui B; Lei Z; Ning X; Liu Y; Li M
Front Immunol; 2023; 14():1171680. PubMed ID: 37304260
[TBL] [Abstract][Full Text] [Related]
7. The Role of Group 3 Innate Lymphoid Cells in Lung Infection and Immunity.
Yang D; Guo X; Huang T; Liu C
Front Cell Infect Microbiol; 2021; 11():586471. PubMed ID: 33718260
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal costimulatory molecules control the activation of mucosal type 3 innate lymphoid cells during engagement with B cells.
Lv X; Zhu S; Wu J; Shi J; Wei Q; Li T; Yang N; Liu C; Qi L; Zang G; Cheng H; Yang Z; Jin C; Wang Y; Cui J; Ueno H; Liu YJ; Chen J
Cell Mol Immunol; 2023 Jul; 20(7):808-819. PubMed ID: 37225838
[TBL] [Abstract][Full Text] [Related]
9. Bcl6 is a subset-defining transcription factor of lymphoid tissue inducer-like ILC3.
Tachó-Piñot R; Stamper CT; King JI; Matei-Rascu V; Richardson E; Li Z; Roberts LB; Bassett JW; Melo-Gonzalez F; Fiancette R; Lin IH; Dent A; Harada Y; Finlay C; Mjösberg J; Withers DR; Hepworth MR
Cell Rep; 2023 Nov; 42(11):113425. PubMed ID: 37950867
[TBL] [Abstract][Full Text] [Related]
10. Innate lymphoid cells type 3 in cancer.
Castillo-González R; Valle-Noguera A; Gomez-Sánchez MJ; Xia P; Cruz-Adalia A
Front Immunol; 2022; 13():1033252. PubMed ID: 36341381
[TBL] [Abstract][Full Text] [Related]
11. Innate Lymphoid Cells in the Maternal and Fetal Compartments.
Miller D; Motomura K; Garcia-Flores V; Romero R; Gomez-Lopez N
Front Immunol; 2018; 9():2396. PubMed ID: 30416502
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors.
Drommi F; Calabrò A; Vento G; Pezzino G; Cavaliere R; Omero F; Muscolino P; Granata B; D'Anna F; Silvestris N; De Pasquale C; Ferlazzo G; Campana S
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296855
[TBL] [Abstract][Full Text] [Related]
13. Regulation and Function of ILC3s in Pulmonary Infections.
Hoffmann JP; Kolls JK; McCombs JE
Front Immunol; 2021; 12():672523. PubMed ID: 33968082
[TBL] [Abstract][Full Text] [Related]
14. Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice.
Montaldo E; Juelke K; Romagnani C
Eur J Immunol; 2015 Aug; 45(8):2171-82. PubMed ID: 26031799
[TBL] [Abstract][Full Text] [Related]
15. Group 3 innate lymphoid cells: A trained Gutkeeper.
Serafini N; Di Santo JP
Immunol Rev; 2024 May; 323(1):126-137. PubMed ID: 38491842
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota as a key regulator of intestinal mucosal immunity.
Wang J; He M; Yang M; Ai X
Life Sci; 2024 May; 345():122612. PubMed ID: 38588949
[TBL] [Abstract][Full Text] [Related]
17. Controversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy.
Zhang Y; Feng X; Chen J; Liu J; Wu J; Tan H; Mi Z; Rong P
Front Immunol; 2023; 14():1134636. PubMed ID: 37063879
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity and diversity of group 3 innate lymphoid cells: new cells on the block.
Satoh-Takayama N
Int Immunol; 2016 Jan; 28(1):29-34. PubMed ID: 26462712
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease.
Buela KA; Omenetti S; Pizarro TT
Curr Opin Gastroenterol; 2015 Nov; 31(6):449-55. PubMed ID: 26398682
[TBL] [Abstract][Full Text] [Related]
20. The role of group 3 innate lymphoid cell in intestinal disease.
Li M; Wang Z; Jiang W; Lu Y; Zhang J
Front Immunol; 2023; 14():1171826. PubMed ID: 37122757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
